Maybe because that study has absolutely nothing to do with DC immunotherapy. The study you have cited is a combination between an anti-psychotic drug (maybe you should look into that, LC) and radiation. LL is listed as the penultimate author, which means she’s contributed less to this study than the higher listed authors. Why would we expect DCVax to be mentioned simply because LL is an minor-contributing author on some non-related study that also deals with GBM? In any case, we should expect LL to have other ventures related to GBM outside of DCVax as her entire career has been focused on GBM.
News 
Market Data 
Discover 
